drugset / Trial / NCT03911921

RSYR for Fatigue Reduction in Cancer Survivors

NCT03911921

Phase 2 Completed 92 enrolled Peking University Cancer Hospital & Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized Phase II trial to establish the efficacy of traditional Chinese medicine (TCM) herbal products above control group for treating fatigue in patients with cancer.

Timeline

Start
2015-06-01
Primary completion
2019-02-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Astragalus Traditional medicine (herbal / TCM)
Subject Renshen Yangrong Tang Traditional medicine (herbal / TCM)